2022 JPAD Article
2022 Journal of Prevention of Alzheimer’s Disease:
ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aβ Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan
2022 Journal of Prevention of Alzheimer’s Disease:
ACU193, a Monoclonal Antibody that Selectively Binds Soluble Aβ Oligomers: Development Rationale, Phase 1 Trial Design, and Clinical Development Plan
2022 Frontiers in Neuroscience:
ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease
2022 AAIC Poster:
Preparation and qualification of soluble AβOs for use in bioanalytical assays supporting AD therapeutics.
2022 CTAD Poster:
Critical evaluation and comparison of biomarker values in commercial CSF with Lumipulse® to support assay development for clinical trials.